Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates
Author(s) -
SoHee Hong,
Hanseul Oh,
Yong Wook Park,
Hye Won Kwak,
Eun Young Oh,
HyoJung Park,
KyungWon Kang,
Green Kim,
BonSang Koo,
Eunha Hwang,
Seung Ho Baek,
Hyeong-Jun Park,
YuSun Lee,
YooJin Bang,
Jaeyong Kim,
SeoHyeon Bae,
Su Jeen Lee,
Ki-Weon Seo,
Hak Kim,
Taewoo Kwon,
Ji Hwan Kim,
Seonghwan Lee,
Eunsom Kim,
YeonHwa Kim,
JaeHak Park,
SangIn Park,
Marta Gonçalves,
Byung Mook Weon,
Haengdueng Jeong,
Ki Taek Nam,
Kyung-Ah Hwang,
Jihye Kim,
Hun Kim,
SangMyeong Lee,
Jung Joo Hong,
Jae-Hwan Nam
Publication year - 2021
Publication title -
science advances
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.abg7156
Subject(s) - immunization , virology , alum , antibody , coronavirus , toxoid , immunology , tetanus , biology , covid-19 , neutralizing antibody , severe acute respiratory syndrome coronavirus , neutralization , medicine , vaccination , chemistry , disease , pathology , infectious disease (medical specialty) , organic chemistry
A previously unknown SARS-CoV-2 vaccine protecting nonhuman primates from SARS-CoV-2 challenge was developed using RBD-P2 and N.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom